Log in

CVE:DXD3D Signatures Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume5,000 shs
Average Volume30,759 shs
Market CapitalizationC$2.66 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
3D Signatures Inc., a personalized medicine company, focuses on the development and commercialization of predictive technological products. Its proprietary software platform predicts the course of certain diseases and personalizes the treatment for individual patients. The company's TeloView software platform measures the stage of the disease, rate of progression of the disease, how different diseases will respond to various therapies, and drug efficacy and toxicity. It is developing five diagnostic and prognostic products for cancers and neurological disorders, including Hodgkin's lymphoma, prostate cancer, multiple myeloma, lung cancer, and Alzheimer's diseases. The company is headquartered in Toronto, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-204-5820922

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book ValueC($0.01) per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$2.66 million
Next Earnings DateN/A
OptionableOptionable

Receive DXD News and Ratings via Email

Sign-up to receive the latest news and ratings for DXD and its competitors with MarketBeat's FREE daily newsletter.


3D Signatures (CVE:DXD) Frequently Asked Questions

Has 3D Signatures been receiving favorable news coverage?

Media stories about DXD stock have trended very negative this week, InfoTrie reports. The research group identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. 3D Signatures earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news about3D Signatures.

Who are some of 3D Signatures' key competitors?

What other stocks do shareholders of 3D Signatures own?

Who are 3D Signatures' key executives?

3D Signatures' management team includes the following people:
  • Dr. Sabine Mai, Co-Founder, Chair of Clinical & Scientific Advisory Board and Director
  • Dr. Sherif Louis, Chief Exec. Officer
  • Mr. Ryan Cheung C.A., CPA, CFO & Director

What is 3D Signatures' stock symbol?

3D Signatures trades on the Canadian Venture Exchange (CVE) under the ticker symbol "DXD."

How do I buy shares of 3D Signatures?

Shares of DXD and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

How big of a company is 3D Signatures?

3D Signatures has a market capitalization of C$0.00.  View additional information about 3D Signatures.

What is 3D Signatures' official website?

The official website for 3D Signatures is http://www.3dsignatures.com/.

How can I contact 3D Signatures?

3D Signatures' mailing address is 211-175 Hargrave St, WINNIPEG, MB R3C 3R8, Canada. The company can be reached via phone at +1-204-5820922.

This page was last updated on 4/5/2020 by MarketBeat.com Staff

Featured Article: Inverted Yield Curve

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel